Active Clinical Trials
142
↑ 12% YoY
Datasets Available
3,847
↑ 28.4K records
Regulatory Approvals
89
FDA, EMA, PMDA
Research Partners
214
↑ 34 new this quarter
HIPAA Compliant
GDPR Ready
21 CFR Part 11
CDISC Standards
SOC 2 Type II
FDA eSTAR Aligned
Clinical Trial Pipeline & Data Availability
\n
Trial ID Indication / Target Phase Enrollment Status Data Access
AZ-CL-2024-0892 HER2+ Breast Cancer / ADC-904 Phase III
1,840/2,000
Active
AZ-CL-2025-1147 Alzheimer's / Tau Inhibitor ZT-44 Phase II
412/640
Recruiting
AZ-CL-2023-0551 Type 2 Diabetes / GLP-1 Analog Phase III
3,200/3,200
Completed
AZ-CL-2025-1289 Rheumatoid Arthritis / JAK Inhibitor Phase I
76/200
Recruiting
AZ-CL-2024-0998 Non-Small Cell Lung Cancer / CAR-T Phase II
180/180
Completed

Data Access & Integration

RESTful Clinical API

Programmatic access to trial metadata, patient demographics (de-identified), and outcome endpoints. Supports CDISC ODM 1.3 & SDTM mappings.

OAuth 2.0 Rate Limited Audit Logged

Secure SFTP Vault

Encrypted file transfer for large CDISC-compliant datasets, raw SAS transport files, and medical imaging cohorts. 256-bit AES encryption in transit & at rest.

AES-256 Multi-Party Auth Retention Policies

Federated Query Network

Run ML models across distributed clinical datasets without moving patient data. Compliant with cross-border data sovereignty regulations.

Privacy-Preserving GPU Enabled Zero-Trust

Request Clinical Data Access

Complete the form below to initiate a data access review. Our clinical data governance team will respond within 3-5 business days with DAA terms and encryption keys.